It's the first new pharmaceutical approach to treating pain in over 20 years, designed to eliminate risks of addiction and overdose associated with opioids.
Kennedy Jr., President Donald Trump’s nominee to lead the Department of Health and Human Services, is back on Capitol Hill on Thursday facing a second Senate panel in as many days as he vies for ...